ArticleScientific reports2025
A population based optimization of convolutional neural networks for chronic kidney disease prediction.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Applications of artificial intelligence in chronic kidney disease: a systematic review.Revista de saude publica · 2026Pooled it
- A novel adaptive multi-scale wavelet Galerkin method for solving fuzzy hybrid differential equations.Scientific reports · 2025Article
- State-of-Charge Estimation of Medium- and High-Voltage Batteries Using LSTM Neural Networks Optimized with Genetic Algorithms.Sensors (Basel, Switzerland) · 2025Article
- Artificial intelligence in chronic kidney disease: Bibliometric and visual analysis of trends and future directions.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chronic kidney disease (CKD) is a global public health concern, and the timely detection of the disease is priceless. Most of the classical machine learning models have the major drawbacks of being unsophisticated, non-robust, and non-accurate. This research work is therefore seeking to introduce OptiNet-CKD, a paradigm based on a DNN that has been integrated with a developed population optimization algorithm (POA) for CKD prediction optimization. POA is unlike gradient-based optimization methods in that it uses an initialized population of networks and perturbs their weight values to provide a broader exploration of the solution space. The model is more robust and less likely to overfit, and the predictions are likely to be more accurate since this approach helps to avoid the local minima problem suffered by gradient-based optimizers. To preprocess it for DNN learning, a CKD dataset with 400 records containing numerical and categorical features was imputed for missing data and scaled for its features. The model was evaluated using performance metrics such as accuracy, precision, recall, F1-score, and ROC AUC. OptiNet-CKD achieved 100% accuracy, 1.0 precision, 1.0 recall, 1.0 F1-score, and 1.0 ROC-AUC from traditional models (logistic regression, decision trees) and even fundamental deep neural networks. Results show that OptiNet-CKD is a reliable and robust prediction method for CKD, with more substantial generalization and performance than the existing methods. A combination of DNN and POA constitutes a promising approach for medical data analysis, especially for the diagnosis of CKD. POA expands the solution space, helping to expunge the model from falling into local minima and giving the model increased power in generalizing complicated medical data. Based on the simplicity of the algorithm, together with the structured formula and the extractions made in the preprocessing step, this framework can be extended to other medical conditions with similar data complexities, providing a potent tool for improving diagnostic accuracy in healthcare.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.